What forms of HRT does the FDA consider safest

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

FDA‑Preferred Lower-Risk Options

Transdermal estrogen (patches, gels, sprays) and oral micronized progesterone are considered lower-risk options for most women who need both hormones, according to guidance from NAMS and the FDA-approved prescribing information for these products. A qualified prescriber may determine whether this combination is appropriate for an individual patient.

Why Transdermal Estrogen Has a Different Risk Profile

• Bypasses the liver: According to FDA Drug Safety Communications and NAMS, skin delivery avoids first-pass liver metabolism, which is associated with a lower risk of blood clots and stroke compared with oral estrogen pills.
• More stable levels: Patches, gels, and sprays may provide steadier estrogen levels, which may lead to fewer fluctuation-related symptoms such as mood changes or headaches.
• Lower clot risk: According to NAMS and ACOG, transdermal estradiol is associated with a lower risk of deep vein thrombosis compared with oral estrogen formulations.
• Metabolic considerations: Transdermal estrogen may have less effect on triglycerides and blood pressure than oral estrogen, according to FDA-approved prescribing information for these products.

FDA‑Approved Forms of Transdermal Estrogen

• Estradiol patches: Available in low, medium, and higher doses. According to FDA-approved prescribing information, the lowest effective dose for the shortest duration consistent with treatment goals is generally recommended.
• Estradiol gel: Applied to the skin daily, allowing precise dose adjustment under prescriber guidance.
• Estradiol spray: A metered-dose spray providing consistent absorption per application.

Progesterone Options for Women With a Uterus

According to the FDA-approved prescribing information for Prometrium, oral micronized progesterone is a body-identical, FDA-approved progestogen. According to NAMS, it may be associated with a more favorable tolerability profile regarding blood pressure, mood, and cholesterol compared with some synthetic progestins.

• Protects the uterine lining: Progesterone is required in women with a uterus to prevent estrogen from overstimulating the endometrium, per FDA-approved prescribing information.
• Tolerability: According to NAMS, micronized progesterone may be associated with improved sleep and fewer mood-related side effects compared with certain synthetic progestins.
• Breast risk considerations: According to the WHI and subsequent research cited by NAMS, micronized progesterone may be associated with a different long-term breast risk profile compared with older synthetic progestins; a qualified prescriber should discuss individual risk factors.

When Estrogen Alone May Be Appropriate

According to FDA-approved prescribing information, women who have had a hysterectomy do not require a progestogen and may use transdermal estradiol alone. A qualified prescriber determines whether this is appropriate for a given patient.

Local Vaginal Estrogen

For vaginal dryness or urinary symptoms, according to ACOG and NAMS, low-dose vaginal estrogen (cream, tablet, or ring) involves minimal systemic absorption at recommended doses. A qualified prescriber may recommend this option when symptoms are localized.